Talk:Efonidipine

Pharmaceutical company marketing
In the section "Efonidipine-The Best in Class", the author appears to rely on cherry-picking of primary sources to make claims that are not made in the sources themselves, and not verified by secondary medical sources. I think this is pharmaceutical company marketing. The rest of the article should get a thorough peer review as well. — Preceding unsigned comment added by 108.16.253.48 (talk) 14:12, 30 September 2018 (UTC)